Higher-order disease interactions in multimorbidity measurement: marginal benefit over additive disease summation

By sjmartinez • November 21, 2024

Wei MY, Tseng CH, Kang AJ. Higher-order disease interactions in multimorbidity measurement: marginal benefit over additive disease summation. J Gerontol A Biol Sci Med Sci. 2024 Nov 20:glae282. doi: 10.1093/gerona/glae282. Epub ahead of print. PMID: 39565288.

Tags: chronic conditions, disease interactions, General Internal Medicine, Multimorbidity, multimorbidity-weighted index, Publications

Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for Quality Improvement

Quigley DD, Predmore Z, Panayotou MS, Elliott MN, Hays RD. Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for[...]

Mechanisms of Benefit in Geriatric Assessment (GA): Approach-Oriented Coping Mediates Outcomes of a GA-Guided Supportive Care Intervention (GAIN-S)

Bergerot CD, Bergerot PG, Razavi M, França MVDS, Cerveira JA, Fuzita WH, Philip EJ, Ferreira CGM, Buso MM, Nipp R, El-Jawahri A, Soto-Perez-de-Celis E, Dale[...]

A Cluster Randomized Controlled Trial to Improve Influenza and Tdap Vaccination Rates for Pregnant Women

Rand CM, Bender R, Albertin C, Schrader ARB, Humiston SG, Olson-Chen C, Westen EA, Chen J, Hsu YJ, Parker Fiebelkorn A, Vangala S, Szilagyi PG.[...]